chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the swelling in generalized and it looks like he worked out more on his left side & now looks buff; left shoulder swelled up again and the swelling went into his armpit & chest area; and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again; This spontaneous case was reported by a consumer and describes the occurrence of GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff), PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0033F21A, 012M20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff), PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again). At the time of the report, GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff) had not resolved and PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.   This case was linked to MOD-2021-405151 (Patient Link).
C/O stomach ache within 30 minutes of receiving flumist. Temp 100.4 @ interview with child. Child stated she was sick & vomited 5 times the night prior.
Father called 9/15/06, states 11 days after getting shots, pt got chicken pox. Father subsequently got shingles. Pt was seen by another provider.
THROWING UP - DIARREA - EXCESSIVE HEADACHE - SORE THROAT - ACHES AND PAINS
Patient presented to the ED and was subsequently hospitalized on 2/26/21 for acute blood loss anemia. He also presented to the ED on 4/20/21 and was subsequently hospitalized for A-fib with RVR.
Patient came to clinic to receive 2nd dose of Moderna. He was accidently given Pfizer instead of Moderna
12/16/21 presents to ED for "shortness of breath". PMHx of "HTN, dyslipidemia, intraparenchymal hemorrhage"
Starting morning after receiving the flu shot the patient woke up every day for 1 week with cold sweats, nausea, vomiting, low grade headache, sore muscles in the back and chest. The nausea and vomiting led to an 8 pound weight loss over the course of that 1 week.
Patient states she has burning, achy and shooting pain in her left arm. Pain is centered in shoulder. Onset of pain was noticed when patient stopped taking meloxicam (taken for another injury). Patient went to urgent care and was prescribed muscle relaxers.
Injection site pain Extreme fatigue Muscle and joint pain Earache Fever Chills Nausea Weakness Swollen lymph nodes 24 hours of moderate symptoms followed by mild lingering symptoms
the day following vax pt devel abnormal cramps. needing er. treated w/iv fluid & oral med.
Information has been received from a physician concerning a 34 year old female who as a child was vaccinated with MMR vaccine live. Subsequently, the patient wanting to get pregnant had titers done. The measles titer was reportedly low. The patient's OB/GYN requested that she receive MMR again. Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested.
Fever reaching 103.6 despite antipyretics. Sun opal episode at home 24 hours after injection.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 24-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 with hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
After administration of MMR on 2/24/03  pt developed parotitis. Initially went to the dentist and complained of jaw pain. Pt treated with Keflex 500 mg BID for 20 days beginning 4/2/03. Did not return for recheck but called and stated she was fine.
Within in seconds of receiving I had a tingling under the left side of my tongue that went away as fast as it came.After about 4-5 hours or receiving the vaccine I experienced medium to excruciating pain in my left arm to the wrist at times for a period of 2 days.  Following another half day of site and upper shoulder/arm soreness, During this period I took 600mg of Motrin every 4-6 hours with what I felt gave little relief. 1/11 no sx, resolved
Information has been received from a pharmacy technician concerning her 14 year old female daughter with no previous medical history reported who in May 2007, was vaccinated with the first dose of GARDASIL and in July 2007 was vaccinated with the second dose of GARDASIL. There was no concomitant medication. The patient received the second dose of GARDASIL and about one week later she woke in the middle of the night. The patient's lips and ears were swollen and her whole body was red. The patient then developed diarrhea and projectile vomiting followed by chills that caused her whole body to shake. The whole episode lasted for about one hour to one and one half hour. The patient has had 6 similar "bad" reactions, the worst was in January 2008. The patient has had numerous "moderate" reactions (at least 6 in 2008) which involved diarrhea, vomiting or nausea. The patient has also sought treatment for continual menstrual bleeding since September 2007 that was treated with hormones (birth control). The patient was hospitalized in September 2007 for dehydration. The patient experienced nausea and felt like she was going to pass out on 22-Sep-2008. She has also experienced breathing difficulty (EPI PEN) and was starting to be emotionally effected (wanted to be by herself). The patient never received the third dose of GARDASIL. Numerous blood tests and unspecified tests were performed (resulted were not provided). There was no product quality complaint. As of 29-SEP-2008; the patient was not recovered. Lips and ear swelling; whole body red, diarrhea, vomiting, chills, nausea, going to pass out, continual menstrual bleeding, breathing difficulty and emotionally affected were considered to be disabling by the pharmacy technician. Breathing difficulty requiring EPI-PEN was considered to be an other important medical event by the pharmacy technician. Additional information has been requested.   10/10/08 Reviewed ER records of 8/9-8/10/2007. FINAL DX: acute allergic reaction, vomiting & diarrhea Records reveal patient experienced diarrhea, lips swelling, vomiting, itching all over, flushed skin.  3rd episode of same s/s since 7/14/07.  Admitted for 23 hour observation & tx w/IV benadryl, oral antihistamines & steroids.  Responded well & d/c to home on continued antihistamines & tapering steroids as well as epi-pen.  11/03/08 Reviewed PCP medical records. FINAL DX: angioedema; pruritus Records reveal patient experienced good overall health on 5/25/07 sports physical & HPV #1.  Received HPV #2 on 7/25/07.  No lot numbers recorded.  RTC 8/24/07 w/sore throat, nasal drainage; no other problems reported since hospitalization.  Urticaria had resolved.  Tx w/antibiotics & continued on sinulair & zyrtec.  Referred to allergist 12/04/2007 s/p 4 additional episodes last being 9/24/07 of angioedema of lips & ears w/marked erythematous changes of skin.  Had persistent feeling of being hot & pruritus of shoulders, back & jaw line.  Developed anaphylaxis 1/8/08 after use of neosporin; tx w/epi & steroids.  Recurred 2/08 w/vomiting & diarrhea as well.  RTC5/6/08 w/sinusitis.
Very slight vertigo; Very slight nausea; Maybe a little bit of muscle ache but no fever; This is a spontaneous report from a contactable consumer. This male consumer reported for himself that he on an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included sulfasalazine taken for an unspecified indication, start and stop date were not reported. On an unspecified date the patient experienced very slight vertigo, very slight nausea and maybe a little bit of muscle ache but no fever. It was reported that patient had his first PFIZER COVID-19 Vaccination shot yesterday (at this point of report) at noon and that would be about 20hours ago. And then, patient went to sleep and then when he woke up a couple of hours ago, patient had mild symptoms, like on a 10 scale. Patient had like a 1 or 2. Very slight vertigo, very slight nausea and maybe a little bit of muscle ache but no fever. This the things that PFIZER was seeing in some of its population. Name of the vaccine: Pfizer COVID-19 vaccine. When paraphrased the concern, patient confirmed the same. Patient was informed about the role of PFIZER Drug Safety and PFIZER Medical Information. Patient was provided with the contact for PFIZER Medical Information. Patient further stated, he have if it was possible for him to get the second shot of PFIZER or whether it would be advisable for him to switch to a different vaccine. Reason for no lot number: of COVID-19 Vaccine was reported as other. Patient stated, he did not know if he have that immediately available there. patient can't get my hands on that. Patient stated, there was one medication that he had taken that might be related, it was Sulfasalazine, that was his regular. That was his routine medication (hence captured as Medical History). Patient stated he did not received any treatment. The outcome of events were unknown.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
oval sized pink area that is 2 1/2 inches long and is warm to the touch; pink area the size of a dime; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (pink area the size of a dime) and VACCINATION SITE WARMTH (oval sized pink area that is 2 1/2 inches long and is warm to the touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) for Pain in knee, ATENOLOL, ALOPURINOL, HCTZ, METFORMIN, OLMESARTAN and ATORVASTATIN.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 16-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (pink area the size of a dime). On 20-Feb-2021, the patient experienced VACCINATION SITE WARMTH (oval sized pink area that is 2 1/2 inches long and is warm to the touch). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE ERYTHEMA (pink area the size of a dime) and VACCINATION SITE WARMTH (oval sized pink area that is 2 1/2 inches long and is warm to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pregnant/Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant/Pregnancy) in a 27-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1-2 drinks per week) on 01-Nov-2020. Concurrent medical conditions included Sulfonamide allergy (Sulfa) and Asthma. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and PROGESTERONE from 01-Jan-2020 to an unknown date for Pregnancy.    On 05-Feb-2021 at 1:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 18-Nov-2020 and the estimated date of delivery was 25-Aug-2021. On 05-Feb-2021 at 1:45 PM, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant/Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  eleventh week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant/Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, Pregnancy test: positive (Positive) Positive. On 19-Jan-2021, Ultrasound antenatal screen normal: normal (normal) no findings.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.  The patient's estimated date of conception was 20-Nov-2020.  It was reported that, the patient had miscarriage in Oct-2020.
reactions to the first dose but not to the second dose.; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (reactions to the first dose but not to the second dose. ) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reactions to the first dose but not to the second dose. ). At the time of the report, VACCINATION COMPLICATION (reactions to the first dose but not to the second dose. ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.  Nurse said that she heard of coworkers and people who had reactions to the first dose but not to the second dose.  Nurse says some of these patients took the Moderna Covid-19 vaccine but she is not sure if all of the patients took the Moderna Covid-19 vaccine.  Nurse said that she would encourage these people that she knows to report their adverse events.
Nausea and vomiting with a fever on tuesday am (11.17) on Wednesday (11.18) also had a rash all over.
Pt appears pale and weak States that she has numbness and tingling to L upper and lower extremities, Nausea, severe headache. Pt also has chest pain and is gripping at chest and is SOB. Pt states that she received vaccine at 1600 yesterday. Severe pain to L arm (site of injection).
15min p/vax mom found pt limp ?stopped breathing;called 911-began CPR-p/2breaths, pt began breathing cried instantly, vomited x 1;paramedics arrived pt totally well-transported to pediatrician
Initial information received on 27-Nov-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 28 years old pregnant female patient who was feeling dizzy, sweaty, vomiting, nauseous and unable to walk due to weakness, while she received vaccine ADACEL. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported that the patient received vaccine at 30 Weeks of pregnancy. The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Nov-2018, the patient received a 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot U5979AA and expiration date 13-Jun-2020) via unknown route in the left arm. On an unknown date, the patient had been feeling dizzy, sweaty, vomiting, nauseous and unable to walk due to weakness, with 24 hours following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. This was a case of vaccine exposure during pregnancy. (Other relevant tests included No lab data reported). Final diagnosis was nauseous, vomiting, weakness, sweaty, feeling dizzy and unable to walk. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for all the events. List of documents held by sender: none.
Information was received on 07-JUN-2017 from a 66 year old male patient who reported he received a ZOSTAVAX subcutaneous injection for prevention of shingles (dose and lot#/expiration not reported) through a pharmacy in February 2017 (date unspecified). Patient stated that two days later (unspecified date) he began having headaches which started off very mild. Patient stated that as time went on he began to have more frequent headaches (unspecified dates) and they became progressively worse. Patient stated that he was still presently having headaches. Patient asked his unspecified pharmacist if this was normal and was told that headaches were a possible side effect from the ZOSTAVAX injection but they should not last this long. Patient stated he has had numerous unspecified vaccines over the years, because he travels to various countries, but has never had this happen before, so he could only assume that the headaches may be caused by the ZOSTAVAX injection. Patient stated he has not had any other symptoms besides the headaches. Patient also stated that he takes losartan, atorvastatin calcium (LIPITOR), morniflumate (FLOMAX), vitamin D3 and loratadine (CLARITIN) (dates of use, dose, frequency and indications unspecified). Patient noted he was scheduled to see and consult with his physician on 12-JUN-2017 for further evaluation. No other information provided. Adverse event was filed as precaution as it cannot be determined if ZOSTAVAX is the cause of the patient's headaches. Patient's present status was not recovered. Additional information has been requested.
lt arm has 2 1/2 x 2 1/2cm red swollen area, warm to touch;pt states that area was sore to touch @ first but feels better today;local rxn-no rx given;pt mom will f/u;
This is a spontaneous report from a contactable pharmacist. A 63-year-old female patient received PREVNAR 13, (Lot S31257, Expiration date Jul2018, NDC number: 0005197102) intramuscular in left deltoid on 17Sep2017 about 13:20  at 0.5 ml single dose for immunisation, and FLUARIX QUADRIVALENT, (Lot 3DT97, Expiration date 30Jun2018) intramuscular in left deltoid on 17Sep2017 at unknown dose for immunisation. Medical history included ongoing asthma. Concomitant medication included light steroid 10 mg daily. The patient experienced really bad pain in that arm all the way down past her elbow on 17Sep2017. The event was non-serious. Therapeutic measures taken as a result of  the event included treatment with MOTRIN, TYLENOL, ASPIRIN, with no relief. The outcome was not recovered.
Patient called a couple of days after vaccination and wanted to let us know that she expereinced some swelling and redness down her arm and it lasted a little over a day. It had since resolved when she called. She wanted to let us know in case anyone else experienced it too.
Pt says pain at injection site has radiated to inside of deltoid muscle. She says pain has been constant with times of increased intensity since 4/22/13 when vaccination was given.
This spontaneous report as received from a physician refers to an 11 year old patient of unknown gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 04-AUG-2017, the patient was vaccinated with improperly stored GARDASIL 9 lot # N000326, expiry date 14-DEC-2019 (dose, route of administration were not provided). Data logger was not involved. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments:  US-009507513-1709USA012770: US-009507513-1709USA012767: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA007325: US-009507513-1709USA012766: US-009507513-1709USA012764.
Patient lost consciousness for a few seconds, turned pale, and was put in a wheel chair.  Patient offered ambulance. Moved to private room and laid down on crash pad. (13:25)HR - 86 / R-14 / BP - 118/74. (13:26) more alert talking, oriented, pale, color improved. (13:29) - HR-94 Psox - 98% - BP-115/75. (13:43) - patient sat up and vital signs measured  - HR - 92 / BP - 127/86. (13:53) vitals BP -128/82 - HR-90 / Psox- 98% (14:01) Standing BP - 109/86 - HR-92 / O2 Sat- 99%. Dad went to pick up car. Patient standing and walking without problem . Parents declined EMS, stating patient had had similar episode in the past.
2 days post vaccination, the pt experienced 2 weeks of severe joint pains, muscle aches, headache. Was unable to work for approximately 2 weeks.
Staff member was given a second dose of the covid-19 vaccine around 10:30am on 1/23/2021 about 10-15 minutes after the vaccine was administered the staff member complained of feeling his throat was starting to slightly close and mild chest tightness. Staff member asked for 50mg of Benadryl and that it was administered by mouth. Medical staff monitored staff for another 15-20 minutes and SPO2 saturation was between 97%-98% during staff's complaints and HR was between 80-90. Staff stated that he felt better and stated he would come back if feeling any worse. About one hour after this, staff came back with the complaint that his symptoms were getting worse and his major complaint was chest tightness SPO2 saturation was between 96%-98% and HR was between 90-105. At this time an Epi pen was administered at 11:59am. Staff was then sent to the emergency room for further evaluation.
poor speech, drooling, drooping of left side of face, blurred vision Prescribed Prednisone
My Son has a rectal fever of 103.5 that won't stay down he is extremely fussy and has slept most of the day.